Wealthpoint, LLC Amgen Inc Transaction History

Wealthpoint, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$230.71 - $256.74 $193,334 - $215,148	-838 Closed	0 $0
Q1 2022 Apr 27, 2022	BUY	$219.27 - $242.57 $183,748 - $203,273	838 New	838 $203,000
Q3 2021 Nov 01, 2021	SELL	$212.27 - $248.7 $195,288 - $228,804	-920 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$233.58 - $259.14 $467 - $518	2 Added 0.22%	920 $224,000
Q1 2021 Apr 27, 2021	BUY	$221.91 - $258.6 $203,713 - $237,394	918 New	918 $228,000
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $200,151 - $238,344	-925 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $5,631 - $6,262	24 Added 2.66%	925 $235,000
Q2 2020 Aug 06, 2020	BUY	$197.81 - $242.74 $178,226 - $218,708	901 New	901 $213,000
Q1 2019 May 16, 2019	SELL	$180.87 - $203.88 $25,321 - $28,543	-140 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$178.4 - $208.25 $24,976 - $29,155	140 New	140 $27,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Wealthpoint, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthpoint, LLC with notifications on news.